← Companies|AN2 Therapeutics
AN

AN2 Therapeutics

ANTX·NASDAQMenlo Park CAFounded 201820 employees
Micro CapbiotechPublicInfectious Disease
Platform: NTM Epetraborole
Market Cap
$0.05B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ANTX)
Loading ANTX stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
ANT-256ANT-256NDA/BLA1MultispecificEZH2SHP2iDravet
ElrasotorasibANT-4070NDA/BLA1Gene TherapyWRNVEGFiOvarian CaMigraine
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)
2025-08-03
ANT-256 EMA Filing
Dravet
Past
2027-09-26
Elrasotorasib Ph3 Readout
Wet AMD
Ph3 Readout